In studies of mesalazine [45], azathioprine, and anti-TNF [46, 47] for IBD, depression was found to be an important factor in nonadherence to medication, whereas a study of 356 IBD patients did not find an association between anxiety, depression, and treatment adherence, suggesting that further exploration is needed [48]. This evidence concerns the gene TNF and inflammatory bowel disease.